Press release
AI in Biopharmaceutical Development Market Exclusive Report on Current Trends and Future Insights
The AI in Biopharmaceutical Development Market Size is valued at 603.30 Million in 2022 and is predicted to reach 5931.48 Million by the year 2031 at a 29.2 % CAGR during the forecast period for 2023-2031.
Request for Free Sample Pages: https://www.insightaceanalytic.com/request-sample/1227
Artificial intelligence (AI) has emerged as the frontier technology with the most significant potential to revolutionise the biopharmaceutical industry. ML approach domains include reasoning, knowledge representation, solution search, and machine learning. It can aid in rational drug development, decision-making, selecting the most effective treatment for a patient, customising medications, and maintaining clinical data for future drug development. In drug discovery, AI can differentiate between hit and lead compounds, enabling faster therapeutic target confirmation and structural design optimisation. The FDA (United States Food and Drug Administration) has issued recommendations and initiated numerous initiatives to promote the use of artificial intelligence in the drug discovery and development process.
The biopharmaceutical industry is gaining popularity for artificial intelligence, resulting in market expansion. In addition, rising drug research expenses and a greater understanding of AI's efficacy will be significant market growth drivers in the coming years. A low rate of trial failure, an abundance of software developers for drug discovery, and a high demand for the software among large pharma & biotech firms and research institutes all contribute to the market's expansion. Adopting AI solutions in the clinical trial process eliminates potential obstacles, shortens the clinical trial cycle time, and increases productivity and precision.
The greatest obstacles in this AI-based biopharmaceutical development market are the higher prices of AI-based apparatus, its applications, and software. Aside from this, market restraints for the forecast period include a lack of data sets in drug discovery, a lack of qualified employees, and the absence of regulations and ethics for using artificial intelligence in healthcare. Asia-Pacific is anticipated to acquire prominence between 2022 and 2030 as a result of the expanding software and services industries, as well as funding for their development.
Enquire Before Buying: https://www.insightaceanalytic.com/enquiry-before-buying/1227
biopharmaceutical-development-market-/1227
Prominent market players in the AI in the Biopharmaceutical development market are IBM Watson Health, Google (Alphabet Inc.), Concreto HealthAI, Nvidia Corporation, PathAI, Atomwise, Inc., Deep Genomics, Cloud Pharmaceuticals, Inc., Ai-biopharma S.A.S., and Microsoft Corporation, among others, are some key players operating in the AI in Biopharmaceutical Development Market.
Key Developments in the market
• In Apr 2021, Microsoft focused on healthcare AI with a $19.7B Nuance acquisition Microsoft will shell out $19.7 billion cash for Nuance. With Nuance's speech recognition and conversational AI software under its umbrella, Microsoft will expand its push to bring cloud-based AI tools to the healthcare industry on a broader scale.
• In Apr 2021, Nvidia collaborated with AstraZeneca, the University of Florida, on AI-driven drug discovery. This collaboration will build a model trained using Nvidia DGX SuperPOD, an AI supercomputer, that will allow researchers to evaluate billions of molecules for potential drug candidates faster.
• In Jan 2020, Concerto HealthAI announced an expansion of their existing Precision Oncology collaboration with Pfizer Oncology. The partnership is to advance Concerto HealthAI's use-case engineered Real-World Data (RWD) for various clinical development initiatives across breast, lung, prostate and renal cell carcinoma cancers, which will drive innovative new study designs non-interventional studies.
• In Oct 2019, Novartis and Microsoft announced a collaboration to transform medicine with artificial intelligence. Novartis to establish an AI innovation lab to empower its associates to use AI across the business. Joint research activities will include co-working environments on Novartis Campus in Switzerland, Novartis Global Service Center in Dublin, and Microsoft Research Lab, tackling personalized therapies for macular degeneration, cell & gene therapy, and drug design.
Get Specific Chapter/Information From The Report: https://www.insightaceanalytic.com/customisation/1227
Market Segments
Global AI in Biopharmaceutical Development Market , by Type, 2022-2030 (Value US$ Mn)
• Monoclonal Antibodies
• Vaccines
• Recombinant Proteins
Global AI in Biopharmaceutical Development Market , by Application, 2022-2030 (Value US$ Mn)
• Research And Discovery
• Clinical Development
• Manufacturing & Supply Chain And Other Subsegments
Global AI in Biopharmaceutical Development Market , by End-user, 2022-2030 (Value US$ Mn)
• Biopharmaceutical manufacturers
• Contract manufacturing organizations (CMOs) or contract research organizations (CROs)
• Academic & government research institutes
Global AI in Biopharmaceutical Development Market , by Region, 2022-2030 (Value US$ Mn)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
North America AI in Biopharmaceutical Development Market , by Country, 2022-2030 (Value US$ Mn)
• U.S.
• Canada
Europe AI in Biopharmaceutical Development Market , by Country, 2022-2030 (Value US$ Mn)
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific AI in Biopharmaceutical Development Market , by Country, 2022-2030 (Value US$ Mn)
• India
• China
• Japan
• South Korea
• Australia & New Zealand
Latin America AI in Biopharmaceutical Development Market , by Country, 2022-2030 (Value US$ Mn)
• Brazil
• Mexico
• Rest of Latin America
Middle East & Africa AI in Biopharmaceutical Development Market , by Country, 2022-2030 (Value US$ Mn)
• GCC Countries
• South Africa
• Rest of Middle East & Africa
For More Information: https://www.insightaceanalytic.com/report/global-ai-in-biopharmaceutical-development-market-/1227
Other Related Reports Published by InsightAce Analytic:
Global Cloud-based Solutions for Drug Discovery, Development and Manufacturing Market
Global Clinical Trials Software Market
Global Oncology Informatics Market
Why should buy this report:
To receive a comprehensive analysis of the prospects for the Global AI in Biopharmaceutical Development Market
To receive an industry overview and future trends of the AI in Biopharmaceutical Development market
To analyze the AI in Biopharmaceutical Development Market drivers and challenges
To get information on the AI in Biopharmaceutical Development Market size (Value US$ Mn) forecast to 2030
Significant investments, mergers & acquisitions in the AI in Biopharmaceutical Development Market industry
Sales Office (U.S.) :
344 Grove St Unit #967 Jersey City, NJ 07302
info@insightaceanalytic.com
North America:
+1 551 226 6109
Asia:
+91 79 72967118
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Contact Us:
Priyanka Tilekar
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
Email: info@insightaceanalytic.com
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release AI in Biopharmaceutical Development Market Exclusive Report on Current Trends and Future Insights here
News-ID: 3302786 • Views: …
More Releases from Insightace analytic
Digital Pathology Market Report- Expansive Coverage on the Profit Sources
InsightAce Analytic announces the release of a market assessment report on the "Global Digital Pathology Market Size, Share & Trends Analysis Report By Product (Artificial Intelligence, Scanner, Software, Storage), Type (Human, Veterinary), Application (Teleconsultation, Training, Disease Diagnosis, Drug Discovery), End User (Pharma, Academia, Hospitals)- Market Outlook And Industry Analysis 2031"
The global digital pathology market is estimated to reach over USD 2731.95 million by 2031, exhibiting a CAGR of 12.91%…
Digital Health Market Future Trends and Scope Analysis Report
Digital Health Market Size, Share & Trends Analysis Report By Technology (Tele-healthcare, mHealth, Healthcare Analytics, Digital Health Systems), By Component (Software, Hardware, Services), By Region, And Segment Forecasts, 2024-2031
"Digital Health Market" in terms of revenue was estimated to be worth $248.58 billion in 2023 and is poised to reach $1,004.03 billion by 2031, growing at a CAGR of 19.56% from 2023 to 2031, according to a new report by…
Digital Diabetes Management Market Report on the Untapped Growth Opportunities i …
InsightAce Analytic announces the release of a market assessment report on the "Global Digital Diabetes Management Market - (By Devices (Smart Glucose Meters, Continuous Glucose Monitoring Systems, And Smart Insulin Pens, Smart Insulin Pumps/ Closed-Loop Pumps & Smart Insulin Patches), Application (Diabetes & Blood Glucose Tracking Apps, Obesity & Diet Management Apps), Data Management Software & Platforms And Services), By Device Type (Handheld And Wearable Devices), By End-User(Self/Home Healthcare, Hospitals…
Data Center Liquid Cooling Market Exclusive Trends Analysis with Forecast to 203 …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Data Center Liquid Cooling Market Size, Share & Trends Analysis Report By End-User Industry (Financial Services And Insurance (BFSI), Banking, IT And Telecom, Government And Public Sector, Manufacturing, Healthcare, Retail), Data Center (Hyperscale, Colocation, Enterprise) And Solution (Indirect & Direct Cooling)- Market Outlook And Industry Analysis 2031"
The Global Data Center Liquid Cooling Market is estimated…
More Releases for Biopharmaceutical
Global Biopharmaceutical Stability Testing Market
According to a new market research report published by Global Market Estimates, the Global Biopharmaceutical Stability Testing Market is projected to grow from USD 3.2 billion in 2022 to USD 10.8 billion in 2027 at a CAGR of 13.3% from 2022 to 2027.
Intertek Group plc, Eurofins Scientific, Pacific Biolabs, SGS SA, Element Materials Technology, Almac Group, Merck KGaA, Catalent, Inc., Pace Analytical Life Sciences, Boston Analytical, Kemwell Biopharma, Curia Global,…
Biopharmaceutical Testing Services Market 2021 | Detailed Report
The top-notch information research report published by markets and markets is a vital asset that offers qualitative and quantitative factors of the Biopharmaceutical Testing Services market. The research study and methodologies mentioned in the report examine the critical vendors by considering their contribution to the global market. Furthermore, the report offers an in-depth insight into leading players’ performance based on revenue generation and client requirements. Also, the research report reveals…
BioPharmaceutical Tubing Market 2021 | Detailed Report
According to Market Study Report, BioPharmaceutical Tubing Market provides a comprehensive analysis of the BioPharmaceutical Tubing Market segments, including their dynamics, size, growth, regulatory requirements, competitive landscape, and emerging opportunities of global industry. An exclusive data offered in this report is collected by research and industry experts team.
Get Free Sample PDF (including full TOC, Tables and Figures) of BioPharmaceutical Tubing Market @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5024225
The report provides a comprehensive analysis of…
Biopharmaceutical Market - Massive Growth opportunity Ahead
A new research document with title 'State of the Biopharmaceutical Industry 2021' covering detailed analysis, Competitive landscape, forecast and strategies. The study covers geographic analysis that includes regions and important players/vendors. The report will help user gain market insights, future trends and growth prospects for forecast period of 2021
Get customization & check discount for report @ https://www.htfmarketreport.com/request-discount/3060794-state-of-the-biopharmaceutical-industry
Summary
2021 promises to be a year of continued innovation and change in the…
Biopharmaceutical Logistics Market Is Thriving Worldwide |
The Biopharmaceutical Logistics Market Research Report aims to provide insights that strongly demonstrate the market structure, scope, history, potential, and development perspective. By crossing through the historical and present market status, the Biopharmaceutical Logistics market report provides authentic and reliable estimates for the forecast period.
It became essential to distinguish the saturation of consumption in the Biopharmaceutical Logistics market owing to building competitiveness. Hence, the report furnishes a deep-felt market segmentation…
The Future Of Investing: Biopharmaceutical Logistics Market
The pharmaceutical industry is dynamic and is likely to experience high growth in the coming years. Today, growing sales of drugs and biologics, changing dynamics of the pharmaceutical industry, and stringent regulatory controls are some of the factors boosting the demand for pharmaceutical logistics services.
Outsourcing logistics operations are trending in the pharma industry for cost optimization and technology advancement. Pharmaceutical companies are facing tremendous pressure for cutting down the cost of…
